Price is syncing
Reported smart-money activity is still available below.
1 month
+0.8%
price return
Year to date
+6.8%
price return
Recent earnings
1/4
quarters beat
Big funds
8
hold this stock
News tone
Bullish
21 articles, 7 days
Filed positions and reported activity tied to this stock.
8 funds hold a position and insiders have been net selling.
Real smart money
Insiders
Recent coverage and its overall tone.
News
Coverage leans bullish
10 bullish · 7 neutral · 4 bearish
Tone of tracked coverage
Biomarin Pharmaceutical Inc. (BMRN) Q4 2025 Earnings Report - Results, Call & Slides
Leans bearishJul 25Biomarin Pharmaceutical Inc. (BMRN) Q2 2025 Earnings Report - Results, Call & Slides
BullishJul 25Biomarin Pharmaceutical Inc. (BMRN) Q2 2025 Earnings Report - Results, Call & Slides
BullishJul 25BMRN|BioMarin Pharmaceutical Inc|Price:59.350|Chg%:+0.480
Leans bullishJul 25BioMarin Pharmaceutical Inc (BMRN) Technical Analysis: Support, Resistance, Indicators & Moving Averages
NeutralJul 25Biomarin Pharmaceutical Inc. (BMRN) Q4 2024 Earnings Report - Results, Call & Slides
BullishJul 25Biomarin Pharmaceutical Inc. (BMRN) Q4 2025 Earnings Report - Results, Call & Slides
NeutralJul 25BioMarin Pharmaceutical Inc. (BMRN) Stock Forecasts
NeutralJul 23FMR LLC
Q1 2026 13F
$201.5M
position